SMS Pharmaceuticals' Bachupally facility Unit II successfully completes USFDA inspection

Explore Business Standard

Receives Zero Form 483 observations
SMS Pharmaceuticals has successfully completed, its Fifth US Food and Drug Administration (USFDA) inspection for its Manufacturing facility - Unit-II, located at Plot No.24 & 24B and 36 & 37, S.V. Co-operative Industrial Estate, Bachupally, Ranga Reddy District, Hyderabad-500 090, Telangana, India.No Form 483 observations were issued during the inspection.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Nov 20 2017 | 11:31 AM IST